12:00pm - 12:30pm ET

Fireside Chat

Jacob S. Van Naarden
Jacob S. Van Naarden
Chief Executive Officer and President
Loxo Oncology at Lilly and Lilly Oncology
John Carroll
John Carroll
Founder & Editor
Endpoints News
12:30pm - 1:30pm EST

Expert roundtable

Cigall Kadoch
Cigall Kadoch
Institute Member of the Broad Institute and Assistant Professor of pediatric oncology
DFCI, Harvard Medical School
Dr. Roy D. Baynes
Dr. Roy D. Baynes
Senior Vice President of Global Clinical Development and Chief Medical Officer
Merck Research Laboratories
Susan Galbraith
Susan Galbraith
Executive Vice-President, Oncology R&D
AstraZeneca
James Christensen
James Christensen
Executive Vice President and Chief Scientific Officer
Mirati Therapeutics, Inc.
Kyle Blankenship
Kyle Blankenship (moderator)
Managing Editor
Endpoints News
SHARE ON